Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.53 |
| ▸ | SELP | P16109 | 1/20 | 0.53 |
| ▸ | MAG | P20916 | 7/20 | 0.52 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.51 |
| ▸ | CD22 | P20273 | 6/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30439050 | 0.95 | SIGLEC7 (0.57) | SELLSELPMAGSIGLEC7CD22 | |
| SCHEMBL30439269 | 0.91 | SIGLEC7 (0.62) | SELLSELPMAGSIGLEC7CD22 | |
| SCHEMBL30439275 | 0.91 | SIGLEC7 (0.62) | SELLSELPMAGSIGLEC7CD22 | |
| SCHEMBL29532826 | 0.91 | SIGLEC7 (0.61) | SELLSELPMAGSIGLEC7CD22 | |
| SCHEMBL29806172 | 0.91 | SIGLEC7 (0.61) | SELLSELPMAGSIGLEC7CD22 | |
| SCHEMBL29356627 | 0.91 | SELP (0.62) | SELLSELPMAGSIGLEC7 | |
| SCHEMBL29396615 | 0.91 | SELP (0.62) | SELLSELPMAGSIGLEC7 | |
| SCHEMBL17300130 | 0.91 | SELP (0.62) | SELLSELPMAGSIGLEC7 | |
| SCHEMBL30970765 | 0.90 | SIGLEC7 (0.60) | SELLSELPMAGSIGLEC7CD22 | |
| SCHEMBL29533149 | 0.86 | SELL (0.62) | SELLSELPMAGSIGLEC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025006452-A9 | NEU5GC-LEWISa-TARGETING MOLECULES AND USES THEREOF IN CANCER | SRI INTERNATIONAL (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025006452-A2 | NEU5GC-LEWISa-TARGETING MOLECULES AND USES THEREOF IN CANCER | SRI INTERNATIONAL (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024052405-A1 | ENCAPSULATED MILK SACCHARIDES | INBIOSE N.V. (BE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052406-A1 | BAKED NUTRITIONAL COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4277932-A1 | ANTIBODIES TO CANCER GLYCOSYLATION AND USES THEREOF | Yeda Research and Development Co. Ltd (IL) | 2023-11-22 | — | — | EP | disclosed |
| EP-4192969-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192974-A1 | PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| WO-2022153298-A1 | ANTIBODIES TO CANCER GLYCOSYLATION AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-07-21 | — | — | WO | disclosed |